Recommended For You
Go to your Profile page and select your level of interest in each of our categories. Content seen here will be filtered based upon your ratings.
Infusion Therapy Standards of Practice Crosswalk: 2011/2016
This document highlights the notable revisions of the 2011 Infusion Nursing Standards of Practice to the current 2016 Infusion Therapy Standards of Practice. Clinicians are strongly encouraged to review the entire publication to help ensure infusion practices follow the most current evidenced-based data.
Short Peripheral Catheter (SPC) Checklist: Think Safety, Insert Safely
The SPC Checklist was developed by and for infusion nurses to promote safe practices from start to finish of peripheral infusion therapy.
Infusion Therapy Standards of Practice 2016
This webinar will discuss the recently revised Infusion Therapy Standards of Practice. The presentation will include a brief description of changes as compared to the 2011 Standards, an overview of the methodology used to develop the Standards, and the presentation of selected standards with new or changed recommendations
Noncytotoxic Vesicant Medications and Solutions
INS established a vesicant task force with the goal of developing an evidence-based list of noncytotoxic vesicant medications/solutions. Outside of oncology practice, there is not a list of noncytotoxic vesicants as established by a professional organization. INS identified the need to address this gap based on the following premise:the first step in preventing extravasation is the identification and recognition of vesicant drugs and solutions. The scope of work was limited to creating an evidence-based list of noncytotoxic vesicant medications/solutions and developing an extravasation checklist that outlines risk reduction strategies including early recognition of signs and symptoms of extravasation.
Recommendations for Frequency of Assessment of the Short Peripheral Catheter Site Position Paper
As many organizations choose to follow the Infusion Nurses Society (INS) recommendations for peripheral intravenous (IV) site rotation based on clinical indications rather than a specific time frame, INS recognizes the critical importance of site assessment to identify any signs of complications.
The Role of the Registered Nurse in the Insertion of Nontunneled Central Vascular Access Devices
As the result of requests from several state boards of nursing, INS convened a task force to determine if insertion of central vascular access devices by appropriately trained registered nurses (RNs) should be recommended. The task force consisted of RNs and advanced practice registered nurses with infusion therapy experience in various practice settings. The results are presented in the following INS position paper. (09/14/2017)
Frequency of Assessment of the Short Peripheral Catheter
Short peripheral catheters (SPCs) are the most commonly used invasive device among hospitalized patients, yet nurses often underestimate the risk and the potential for serious consequences associated with peripheral access. Critically important to reducing the risks associated with SPCs are appropriate device and site selection, impeccable insertion technique, and regular and careful assessment for signs/symptoms with prompt catheter removal if present. INS established recommendations for the frequency of SPC assessment as presented in a 2012 position paper and incorporated these recommendations in the 2016 Infusion Therapy Standards of Practice. This presentation will explore and describe assessment recommendations in relation to current evidence.
Short Peripheral Catheter Infiltration: Minimizing Risks to Improve Outcomes
Hospitalized patients receiving medications or fluids via short peripheral catheters (SPCs) are at risk for infiltration. Infiltration can increase patient length of stay, result in repeated vascular access procedures, increase costs by use of supplies and nursing time, lead to short-term and long-term patient harm, and decrease patient satisfaction. Early detection of infiltration can minimize risks by prompt intervention. Quality improvement projects have been directed toward staff education on SPC insertion, maintenance, assessment, and monitoring. This webinar will discuss current research and practice initiatives, as well as the benefits of emerging technology aimed at reducing infiltration.
Intravenous Immunoglobulin Therapy: Treatment Approaches, Product Selection, and Administration Considerations
Intravenous immunoglobulin (IVIg) therapy is a life-saving treatment for patients with primary immune deficiency diseases. More than 75% of IVIg therapy administered in the United States is for patients with autoimmune and inflammatory diseases. However, indications for use continue to increase. In this session, we will discuss the mechanism of action of immunoglobulins, the use of IVIg therapy in certain disease states, and dosing strategies. Current standardization of product selection, approaches to dosing, and administration, which have had a positive impact on patient safety, will also be considered.